Yet Another Theory on the Human Gender Gap in Longevity

Women have a longer life expectancy than men, but why is this? There is no definitive answer to that question, but many competing theories exist. It is a good illustration of the point that the biochemistry of aging is, in detail, enormously complex and still poorly understood as a process with definitive causes and consequences at each stage and in each tissue type. There is a mountain of data, but many more mountains to be cataloged yet, and linking together what is known into a coherent picture is another massive task still in the comparatively early stages. In the research noted here, the authors advance a novel theory on the gender longevity gap, painting the comparative longevity of women as a modern phenomenon driven by a combination of improved medical technology and cardiovascular disease rates.

With regards to the complexity of aging, it is fortunately the case that we don't need a full understanding of the progression of aging if researchers just focused on repairing what we know to be the root cause cell and tissue damage. The situation is akin to that of rust in an ornate metal structure: there is a big difference in effort between (a) just rust-proofing the thing and (b) building a complete module of how rust works and interacts at the molecular level and how exactly, in detail, that causes various structural failure modes over decades of exposure to the elements. In aging research, there is a lot more work on (b) than on (a), which is fine from the pure science perspective where the only goal is complete understanding, but not so good from the point of view of producing therapies for aging in time for you and I to benefit.

Across the entire world, women can expect to live longer than men. But why does this occur and was this always the case? According to a new study, significant differences in life expectancies between the sexes first emerged as recently as the turn of the 20th century. As infectious disease prevention, improved diets and other positive health behaviors were adopted by people born during the 1800s and early 1900s, death rates plummeted, but women began reaping the longevity benefits at a much faster rate. In the wake of this massive but uneven decrease in mortality, a review of global data points to heart disease as the culprit behind most of the excess deaths documented in adult men. "We were surprised at how the divergence in mortality between men and women, which originated as early as 1870, was concentrated in the 50-to-70 age range and faded out sharply after age 80."

Focusing on mortality in adults over the age of 40, the team found that in individuals born after 1880, female death rates decreased 70 percent faster than those of males. Even when the researchers controlled for smoking-related illnesses, cardiovascular disease appeared to still be the cause of the vast majority of excess deaths in adult men over 40 for the same time period. Surprisingly, smoking accounted for only 30 percent of the difference in mortality between the sexes after 1890. The uneven impact of cardiovascular illness-related deaths on men, especially during middle and early older age, raises the question of whether men and women face different heart disease risks due to inherent biological risks and/or protective factors at different points in their lives.

Link: https://news.usc.edu/83648/why-dont-men-live-as-long-as-women/

Comments

Reason,

When you say "With regards to the complexity of aging, it is fortunately the case that we don't need a full understanding of the progression of aging if researchers just focused on repairing what we know to be the root cause cell and tissue damage." Why do you think most researchers don't seem to follow this thought process? Is the engineering/repair approach not viewed as scientific, because they want to have a full understanding of aging before devising treatments? That's the vibe I get from it... it's not considered real science. It just seems so odd that there is still so much focus on the metabolism approach than the repair approach... though I guess it's seen as less radical.

Posted by: Ham at July 8th, 2015 9:17 AM

Ham you should listen to Irina Conboys "Beyond Parabiosis" on youtube and see what she has been doing with just a few signalling pathways. That an the area of telomerase research offer great promise.

There is nothing wrong with the idea of repairing damage per se and I believe a number of SENS concepts are good, even if they have little chance to deliver them in the near future. I would really like to see them develop the foam clearing technology that would be huge, and help Dr Campisi deliver her Senescent cell removal. Plaques and dead cells need removing whichever side of the aging fence you sit, or if you are like me and follow the telomere/epigenetic theory of aging.

I say nothing wrong with damage repair because it fits in with the model that aging is a mixture of program and damage so both things need to be addressed if total rejuvenation is to be seen. Yes I talk about telomeres a lot but that is because I understand how they work, how they play a key role in gene expression and how they can revert cell age though said expression. Not the total answer to aging but they are a huge player.

Posted by: Steve H at July 8th, 2015 12:31 PM

Ham for your enjoyment. Irina uses a small molecule approach to influence signalling and is working on stem cell rejuvenation by de-aging the stem cell niche. This is a very promising area IMO and would work in unison with telomere restoration.

https://www.youtube.com/watch?v=2IGpJTobI3k

Posted by: Steve H at July 8th, 2015 12:33 PM

I'll check it out. I've been listening to some more of Dr. Fossel's talks as well.

Posted by: Ham at July 8th, 2015 1:46 PM

@Ham: Partially it's the scientific culture to go for understanding before application, and partially it is the regulatory system as it presently stands. These combine to make it very hard to get funding for later stage research and trials unless you can demonstrate complete end to end mechanisms. Showing benefits without more than a hypothesis as to why they exist usually isn't enough; there are plenty of areas in which compelling benefits have emerged in animal studies but there is little impetus to follow on with trials, e.g. granulocyte / leukocyte transfer therapies for cancer.

Posted by: Reason at July 8th, 2015 3:41 PM

I figured that was the gist of it... This obviously needs to change though, but that seems like it's going to be a long and hard road still. I know most of us aren't expecting much to come out of that FDA meeting two weeks ago regarding aging, but if they softened their stance on it a bit, I'm sure it would be a great boon to the field.

Posted by: Ham at July 8th, 2015 4:10 PM

"Why do men die sooner? They want to!" -- Henny Youngman

Posted by: Blank Reg at July 8th, 2015 5:38 PM
Comment Submission

Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.